Targeting PTTG has been explored in prolactinoma, glioma, follicular thyroid, and cervical cancer cell lines as well as in vivo mouse models of lung cancer and hepatoma and demonstrate the therapeutic promise of PTTG inhibition [110]. Here, PTTG1 is linked to lung cancer.